Previous Article | Next Article ![]()
Infection and Immunity, December 2000, p. 6865-6870, Vol. 68, No. 12
Program in Vector-Borne Diseases, Animal Disease
Research Unit, Agricultural Research Service, U.S. Department of
Agriculture, and Department of Veterinary Microbiology and Pathology,
Washington State University, Pullman, Washington 99164
Received 17 July 2000/Returned for modification 4 September 2000/Accepted 16 September 2000
The Babesia bovis merozoite surface antigen 1 (MSA-1),
a member of the variable merozoite surface antigen (VMSA) family, is an
immunodominant glycoprotein which elicits antibodies that inhibit erythrocyte invasion. While antigenic polymorphism is a general feature
of vmsa genes, the molecular basis and extent of
msa-1 sequence polymorphism have not been well
characterized. In this study we defined the msa-1 locus in
the biologically cloned Mexico Mo7 strain of B. bovis and
identified the sequence differences between MSA-1 antigenically
dissimilar strains. We then determined whether sequences conserved
between distinct msa-1 alleles would induce cross-reactive
CD4+ T lymphocytes or inhibitory antibodies. The
msa-1 locus in Mo7 contains a single msa-1 gene
flanked by transcribed genes with no sequence homology to members of
the VMSA gene family. Argentina B. bovis strains R1A and
S2P have msa-1 genes with amino acid sequences that are
98.8% identical to each other, and antibodies against S2P MSA-1
cross-react with native R1A MSA-1. In contrast, identity between the
Argentina and Mexico Mo7 msa-1 alleles is only 52%, with
no continuous stretch of identity longer than 16 amino acids. Despite
limited sequence conservation, antibodies against R1A MSA-1 were able
to inhibit invasion of erythrocytes by Mo7 merozoites. The results
indicate that inhibition-sensitive epitopes are conserved despite
significant sequence divergence between Mexico and Argentina strain
alleles and support a conserved functional role for polymorphic MSA-1
in erythrocyte invasion.
Babesia bovis and related
vector-borne apicomplexan hemoprotozoa such as Plasmodium
spp. have an asexual, intraerythrocytic cycle in the mammalian host. In
general the erythrocyte invasion processes for babesial and plasmodial
asexual stages are similar. Extracellular merozoites attach to
erythrocytes through one or more surface antigens (dependent on the
invasion pathway[s] utilized), reorient as necessary to bring apical
organelles close to the attachment interface, and release rhoptry
products at the time of membrane invagination and entry (6,
24). Based on this model, molecules on the merozoite surface and
within the apical organelles are considered vaccine candidates and
several have been shown to induce significant immune protection
(11, 15, 16, 20, 23, 25, 27).
The merozoite surface antigen 1 (msa-1), msa-2,
and babr genes of B. bovis comprise a gene family
termed the variable merozoite surface antigen (VMSA) genes (3, 9,
12). Members of this gene family encode surface proteins
that are proposed to mediate initial attachment of the merozoite
to the host erythrocyte. Immunization with recombinant
MSA-1 (rMSA-1) induces a CD4+ T-lymphocyte response
and immunoglobin G antibodies that inhibit merozoite invasion of
erythrocytes in vitro (2, 8).
Allelic polymorphism is a feature of VMSA genes. Extensive
rearrangement has resulted in multiple genes that have 5' or 3' regions
of sequence identity or close similarity (3).
Cross-hybridization is strong between some alleles but between others
occurs only when the shared 5' or 3' region is utilized as a
probe, indicating limited overall sequence conservation
(9). Antigenic cross-reactivity among strains with
dissimilar alleles has not been demonstrated using monoclonal
antibodies, monospecific sera, or postinfection immune sera (14,
21, 28). Additionally, cattle infected with one msa-1
allelic strain type are not as well protected against challenge with
parasites containing a heterologous msa-1 type as they are
against the homologous strain (8, 26), and
breakthrough populations in cattle immunized with live avirulent
vaccines do not express a cross-reactive MSA-1 (17).
The genetic basis for MSA-1 polymorphism has not been investigated.
Therefore, we wished to determine first whether an msa-1 gene exists in MSA-1 polymorphic strains and, if so, to characterize the polymorphic msa-1 locus and determine whether the extent
of sequence similarity would allow induction of cross-strain inhibitory antibodies and cross-reactive CD4+ T lymphocytes. To
address these issues, we isolated, sequenced, and compared
msa-1 alleles from Mexico strains of B. bovis
with alleles from two MSA-1 antigenically unrelated strains from
Argentina, R1A and S2P. The results indicate limited but significant
sequence identity between Mexico and Argentina strain msa-1
alleles, with conservation of the inhibition-sensitive B-lymphocyte epitope(s).
Parasites.
The Mo7 biological clone of B. bovis
was derived by limiting dilution of the Mexico strain as described
elsewhere (7) and maintained as a cryopreserved stabilate in
liquid nitrogen (19). The Texas B. bovis strain
T2B and the Argentina strains R1A and S2P (kindly provided by Ignacio
Echaide) have been previously described (1, 9). Parasites
were grown in long-term microaerophilus stationary-phase culture by
previously described techniques (13).
DNA analysis, cloning and sequencing.
Genomic DNA was
extracted from cultured merozoites by the standard phenol-chloroform
procedure. For Southern blot analysis, genomic DNA was digested with
restriction enzymes, electrophoresed, transferred to nylon membranes,
and hybridized as previously described (28, 29).
Oligonucleotide probe primer msa1-f (5'-ATGGCTACGTTTGCTCTTTTC-3') was labeled with digoxigenin with a 3' tail as instructed by the manufacturer (Boehringer Mannheim). Primers msa1-f and msa1-r1 (5'-TTGCGGGGATGTTCCTGATGCAG-3') were used to PCR amplify a
digoxigenin-labeled B. bovis msa-1 5' probe. The B. bovis Sau3A genomic library was kindly provided by Doug Jasmer and
was previously described (8). Amplification and cloning of a
genomic fragment of R1A containing the msa-1 locus was
performed by PCR with primers orf1-f (see below) and orf3-f (see
below), using Taq polymerase (Boehringer Mannheim). The 3-kb
product of amplification was cloned into the vector pCR II-TOPO
(Invitrogen) and sequenced. Sequencing was performed with a Prism Ready
Reaction DyeDeoxy Terminator cycle sequencing kit and read with an ABI
PRISM 373 genetic analyzer (Applied Biosystems).The resulting sequences
were assembled and analyzed with the Genetics Computer Group program
(version 9) (4). Protein secondary structure analysis also
was performed using the Baylor College of Medicine search launcher
(http://dot.imgen.bcm.tmc.edu:9331/) (10).
Detection of specific transcripts from the msa-1
gene.
mRNA was extracted from purified B. bovis
merozoites using oligo(dT) affinity columns as instructed by the
manufacturer (Ambion Inc.). MSA-1 mRNA transcripts were detected by
reverse transcription (RT)-PCR analysis using primers msa1-f and msa1-r
(5'- AAATGCAGAGAGAACGAAGTAG-3') specific for the
msa-1 gene. Transcripts of open reading frames 1, 3, and 4 (orf-1, -3, and -4) linked to
the msa-1 gene were amplified using the following specific
primers: orf-1, orf1-f (5'-GATGCTTTGGTTGACGCAAC-3')
and orf1-r (5'-GGCACTCAAACATATCGGTCAGAT-3') orf-3, orf3-f (5'-ATGCTATTGGCTTCCAATGTC-3')
and orf3-r (5'-GTTGTTGGAGTTGCCAGCAATG-3'); and
orf-4, orf4-f
(5'-GATCCAGGAACTATACGCTAATAG-3') and orf4-r (5'-CATGGAAGGCTTATGCCGTTG-3'). Products of RT-PCR were
cloned into vector pCR 2.1 (Invitrogen) and sequenced.
Expression of proteins, production of antibodies, and
immunoblotting.
The msa-1 ORFs were amplified from DNA
extracted from the Mo7, R1A, and S2P strains by PCR using primers
msa1-f and msa1-r. Amplicons were cloned into the vector pBAD/Thio-Topo
(Invitrogen) for expression of rMSA-1. Primers msa1-f and msa1-r were
designed to allow in-frame cloning of the inserts into the
pBAD/Thio-Topo vector to produce expressed thioredoxin fusion proteins.
Inclusion bodies from bacteria induced with 0.2% arabinose were
prepared by sonication and high-speed centrifugation and then dissolved in 6 M urea-0.15 M NaCl-0.1 M Tris-HCl, pH 8.0. Solubilized protein was obtained after centrifugation and dialyzed against
phosphate-buffered saline before immunization of mice. Relative purity
of antigen was confirmed in Coomassie blue-stained sodium dodecyl
sulfate-polyacrylamide gels. Antibodies against Mo7, R1A, and S2P
rMSA-1 were obtained by immunization of three groups of three mice each
with 10 µg of recombinant protein suspended in complete Freund's
adjuvant, followed by three immunizations each of 10 µg of
recombinant protein suspended in incomplete Freund's adjuvant. Murine
antisera were analyzed for reactivity and specificity by immunoblotting
using native antigen from parasitized erythrocytes as previously
described (28).
In vitro inhibition assay.
Inhibition of
B. bovis merozoites was performed as described elsewhere
(9). Briefly, 5 × 105 Mo7 B. bovis merozoites were incubated with control nonimmune or
anti-rMSA-1 immune bovine or murine serum, diluted 1:5 in culture medium, for 30 min at 4°C. An equal volume of 5% (vol/vol) bovine erythrocytes in culture medium was added prior to incubation in triplicate wells of 96-well plates at 37°C in a 5% CO2
atmosphere. The percentage of parasitized erythrocytes (PPE) was
determined after 48 and 72 h by microscopic examination of 2,000 erythrocytes in Giemsa-stained smears prepared from each well. Results
from three independent experiments were analyzed by one-tailed
Student's t test.
T-cell epitope analysis.
Bovine T-lymphocyte lines specific
for the parent Mexico strain of B. bovis were established
with peripheral blood mononuclear cells of cow C97 (2).
Cells were cultured for up to 4 weeks and stimulated weekly with
irradiated (3,000 rads) peripheral blood mononuclear cells as a source
of antigen-presenting cells and semiweekly with B. bovis
(Mexico strain) merozoite membrane (CM) antigen (2). These
cell lines are composed of predominantly CD4+ T cells
(2). T lymphocytes were assayed for antigen-specific proliferation 7 days following the last subculture without antigen. Proliferation assays were carried out in replicate wells of 96-well plates (Costar, Cambridge, Mass.) as described elsewhere
(2), using B. bovis CM, control uninfected red
blood cell membranes (URBC), MSA-1, or control antigen consisting of
Anaplasma marginale rMSP-5 (each at 1 to 25 µg/ml). The
results are presented as the stimulation index (SI), calculated as mean
cpm of cells cultured with B. bovis CM/mean cpm of cells
cultured with URBC or as mean cpm of cells cultured with rMSA-1/mean
cpm of cells cultured with rMSP-5. Responses were analyzed for
statistical significance by Student's t test.
Nucleotide sequence accession numbers.
The nucleotide
sequences reported here have been deposited in GenBank under accession
numbers AF275908 to AF275912.
Genomic analysis of the msa-1 locus.
A clone
designated msa-1-Sau3A was identified in a B. bovis Mo7 Sau3A genomic library by hybridization with a
5' msa-1 probe (8, 9). The 5.52-kb genomic
fragment in msa-1-Sau3A (Fig. 1A) was sequenced and determined to
contain a single copy of msa-1 identical in sequence to the
previously described MSA-1 cDNA clone derived from the Mexico Mo7
strain (8, 9) (GenBank accession no. AF275908). RT-PCR
amplification of Mo7 mRNA using primers msa1-f and msa1-r resulted in a
901-bp fragment identical in size and sequence to genomic Mo7 DNA (Fig.
1).
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Characterization of Allelic Variation in the
Babesia bovis Merozoite Surface Antigen 1 (MSA-1) Locus
and Identification of a Cross-Reactive Inhibition-Sensitive MSA-1
Epitope

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (12K):
[in a new window]
FIG. 1.
Genomic analysis of the B. bovis
msa-1 locus. (A) Map of the Mo7 msa-1 locus based on
sequencing of a 5.520-kb fragment contained in the
msa-1-Sau3A genomic clone. The four ORFs designated by
patterned boxes correspond to the following genes: orf-1,
low homology to polyketide synthase gene from Streptomyces
spp.; orf-2, msa-1; orf-3,
significant homology to N-methylaspartate receptor protein gene;
orf-4, low homology to a hypothetical gene of C. elegans. Arrows indicate the orientation of the coding DNA strand.
Primer sites (orf1-f, orf1-r, msa1-f, msa1-r, orf3-f, orf3-r, orf4-f,
and orf4-r) are designated above and below the map of the
fragment, with primer orientation indicated by arrows.
EcoRI sites and the size of the corresponding
EcoRI fragment (2.4 kb) are shown below the map. Intergenic
regions (white boxes) and the introns in orf-3 and
orf-4 (black boxes) are indicated. (B) Transcriptional
analysis of the B. bovis msa-1 locus represented by an
ethidium bromide-stained agarose gel of amplicons specific for
each of the ORFs encoded in clone msa-1-Sau3A. For each ORF,
three lanes are depicted. Lane 1 represents amplification of Mo7 mRNA
with reverse transcriptase, lane 2 is a no-reverse transcriptase
control, and lane 3 represents amplification of DNA. Size markers are
shown at the right.
|
Characterization of msa-1 alleles in antigenically distinct strains of B. bovis. PCR amplification of DNA from the Texas T2B and Argentina R1A and S2P strains using primers msa1-f and msa1-r, which flank the complete ORF of the msa-1 gene in the Mo7 strain (Fig. 1), resulted in bands of approximately 900 bp for each strain. Analysis of the predicted amino acid sequence of the T2B-derived DNA (GenBank accession no. AF275911) showed absolute identity with Mo7 msa-1. This result is consistent with previously detected cross-hybridization of T2B DNA in Southern blots using labeled probes derived from msa-1 of the Mo7 strain (9), as well as antibody and T-lymphocyte cross-reactivity between Mo7 and T2B MSA-1 (2, 21). Together, these data indicate that identical allelic forms of the msa-1 gene are encoded and expressed in the Texas T2B and Mo7 strains.
Sequence comparison of msa-1 amplified from the Argentina strains R1A (GenBank accession no. AF275910) and S2P (GenBank accession no. AF275909) demonstrates a high degree of identity (98.8%), the putative products differing by only eight amino acid changes, including three substitutions and a 5-amino-acid insertion in the S2P MSA-1 (Fig. 3A). However, sequence comparison of Mexican and Argentine MSA-1 shows extensive divergence (Fig. 3A), with overall only 52% amino acid identity between Mo7 and R1A. Predicted products of ORFs for the Argentina R1A and S2P msa-1 (334 and 339 amino acids, respectively) are longer than the predicted Mexico msa-1 ORF product (319 amino acids). The Mo7 and T2B msa-1 alleles are identical to the Argentine allele in the 5' (first 42 nucleotides) and 3' (last 51 nucleotides) regions, consistent with the general pattern of shared sequences among other members of the VMSA gene family (3, 9, 12). Starting at amino acid position 118 of the Mo7 sequence (amino acid position 126 of the Argentine sequence), there is a continuous stretch of 11 identical amino acids (Fig. 3A). Other identical short motifs are distributed throughout the sequence (Fig. 3A). RT-PCR analysis of R1A mRNA using primers msa1-f and msa1-r yielded a 900-bp band identical in size and sequence to the band obtained with R1A genomic DNA as a target for amplification (data not shown).
|
In vitro inhibition.
To address whether sequences
conserved between the Mexico and Argentina strain alleles encode any
shared inhibition-sensitive B-lymphocyte epitopes, the homologous and
heterologous inhibitory activities of antibodies raised against rMSA-1
were determined. Monospecific bovine serum antibodies against
cDNA-encoded Mo7 rMSA-1 strongly neutralized Mo7 merozoite invasion
(Fig. 4A), consistent with previous
research showing homologous strain inhibition (8, 9).
Similarly, murine antiserum against Mo7 rMSA-1 also inhibited invasion
of B. bovis Mo7 merozoites (Fig. 4A). Serum antibodies
against R1A rMSA-1 bound the expected 45-kDa native protein in the R1A
strain and also cross-reacted with the 42-kDa native protein present in
the Mo7 strain (Fig. 4B). This anti-R1A serum significantly inhibited
the invasion of heterologous Mo7 merozoites (anti-R1A MSA-1 serum,
1.5% ± 0.7% PPE: control nonimmune serum, 5.3% ± 2.3% PPE,
P < 0.02) (Fig. 4A). In contrast, antiserum induced by
immunization of mice with Mo7 rMSA-1 did not bind R1A MSA-1 (Fig. 4B).
|
T-lymphocyte responses.
Mexico strains of B. bovis
have been previously shown to induce an MSA-1-specific CD4+
T-lymphocyte response that does not cross-react with MSA-1 in Australia
and Israel strains (2). To determine if the sequences conserved between R1A and Mo7 alleles of MSA-1 encode a cross-reactive T-cell epitope, we tested the effect of purified rMSA-1 on the proliferation of B. bovis-specific short-term T-lymphocyte
cell lines isolated from cattle infected with the parent Mexico strain of B. bovis. The cell lines proliferated in response only to
rMSA-1 derived from the Mo7 Mexico strain, not with rMSA-1 derived from the Argentina strain R1A or S2P (Fig. 5).
|
| |
DISCUSSION |
|---|
|
|
|---|
Polymorphism among B. bovis strains has previously been reported to include a complete lack of MSA-1 B- and T-lymphocyte cross-reactivity (2, 14, 21, 26, 28). This suggested that within the population there are msa-1 alleles that encode immunologically unique MSA-1 molecules or, alternatively, that msa-1 genes in other strains do not exist. In the present study, using B. bovis strains from North and South America, which previously had been shown not to contain cross-reactive MSA-1, we identified two msa-1 alleles which differ by 48% of the deduced amino acids. Thus, while allelic variation is pronounced, msa-1 is maintained in the genome, presumably due to a necessary functional role for MSA-1 in merozoite invasion.
The VMSA family of surface proteins, of which MSA-1 is a member, also includes the MSA-2, a 44-kD glycoprotein (7, 9, 12, 22), and products of the babr genes, initially detected as a polymorphic gene family in which at least some members are tandemly arranged in the genome (3). Sequence analysis of the msa-1 locus in the Mo7 and R1A strains demonstrated that no other vmsa-related genes are present in close linkage to msa-1. Thus, not all the members of the vmsa family are tandemly arranged. Chromosomal arrangement of the vmsa family may determine the genetic mechanisms involved in msa-1 evolution and the generation of msa-1 sequence variation (5). Gene homogenization through unequal recombination or gene conversion is typically associated with evolution of genes arranged in tandem arrays and therefore is less likely to be a major mechanism for evolution of the msa-1 locus. It is more probable that homologous recombination during sexual stages in the tick vector is involved in generation of msa-1 alleles encoding polymorphic MSA-1 molecules.
Sequencing of the 5.5-kb genomic fragment obtained from the Mo7 strain, together with Southern hybridization experiments, strongly suggests that msa-1 is present as a single-copy gene in the Mo7 strain. Within the 5.5-kb genomic fragment harboring the single msa-1 gene there are at least four other genes that are transcribed in merozoites, including continuous and discontinuous ORFs located in both strands. This type of compact genomic organization resembles that of other known B. bovis loci such as rap-1 (29). Of note, the population of parasites in the uncloned R1A strain also appear to contain a single msa-1 copy with conservation of 5' and 3' ORFs flanking msa-1. If this feature is maintained broadly, it may allow for the direct cloning of other polymorphic msa-1 genes from B. bovis strains with immunologically unique MSA-1 glycoproteins.
Overall sequence identity between the Mexican and Argentine msa-1 alleles is much greater than between msa-1 and other members of the VMSA gene family (3, 9, 12). The longest stretches of sequence identity between the two MSA-1 proteins are in the amino (14 amino acids) and carboxy (22 amino acids with one conservative substitution) termini, consistent with the regional 5' and 3' pattern of sequence conservation among other vmsa genes (9). Prior to this study, the limited sequence conservation between msa-1 alleles had not been demonstrated to encode shared epitopes. Now we demonstrate that B-lymphocyte cross-reactivity can occur between MSA-1 of divergent alleles and that cross-reactive antibodies can inhibit merozoite invasion in vitro. In contrast, the absence of continuous stretches of identical amino acids long enough to constitute CD4+ T-lymphocyte epitopes is reflected in the lack of cross-reactive T-cell responses. Heterologous binding of R1A rMSA-1-specific antibodies to Mo7 MSA-1 in immunoblots is weaker than homologous binding. The reason for this reduced binding is unknown; possibly the epitope(s) recognized by cross-reactive antibodies is conformational and is not well represented in the partially denatured antigen used in immunoblots. However, we have tested the same serum in indirect immunofluorescence assays and find the same relative degree of homologous and heterologous binding (data not shown), suggesting that conformation is at least not a major cause of the differences observed. The cross-reactive epitope(s) also may be encoded by a slightly different sequence and thus not identical, resulting in a reduced affinity of heterologous antibody binding. A more likely explanation is that only a small percentage of the total antibodies generated against R1A rMSA-1 recognize a shared epitope. This explanation is consistent with the one-way cross-reactivity observed and suggests that the B-lymphocyte epitope encoded at least in part by sequences shared between alleles is not immunodominant. The limited cross-reactivity, combined with the lack of conserved CD4+ T-lymphocyte epitopes to provide help for antibody production, constitutes a severe constraint to induction of cross-protective immunity by MSA-1 immunization.
As noted above, sequence identity between the Mexican and Argentine msa-1 alleles is limited to the extreme 5' and 3' regions, the 11-mer peptide starting at position 118 of the Mo7 sequence (amino acid position 126 of the Argentine sequence) and small motifs of five amino acids or less throughout the sequence. The amino-terminal conserved region is typical of a hydrophobic signal sequence, with a potential cleavage site between amino acids 19 and 20 (4), and the carboxy-terminal 22 amino acids comprise a second hydrophobic domain consistent with the signal for attachment of the glycosylphosphatidylinositol anchor (4, 7) characteristic of all members of the VMSA family. BLAST and pattern searching of the database is not informative as to a potential function for the conserved 11-mer or any of the other smaller conserved motifs. Thus, how this limited sequence identity among alleles allows conservation of MSA-1 function is unknown. However, conservation of hemoprotozoan merozoite surface protein function in erythrocyte invasion can occur with significant sequence variation. For example, the primary erythrocyte binding region of Plasmodium falciparum MSP-119 can be altered beyond the retention of antibody cross-reactivity with no apparent effect on invasion or growth in vitro (18). We hypothesize that the limited sequence shared among msa-1 alleles allows merozoites expressing antigenically distinct but structurally similar molecules to invade erythrocytes via the same or a redundant pathway.
In summary, molecular characterization of msa-1 variation indicates limited but significant sequence identity between alleles in the Argentina and Mexico strains of B. bovis. While previous studies have indicated that these two alleles encode immunologically unique MSA-1 molecules, sequences conserved between them encode at least one shared B-lymphocyte epitope recognized by inhibitory antibodies against the Argentina R1A strain rMSA-1. If these same sequences are shared among other strains for which MSA-1 cross-reactivity cannot be demonstrated, it might be possible to enhance cross-inhibition of invasion by more specifically targeting the MSA-1 regions required for conservation of function. Finally, the data support the hypothesis that there are only minimal constraints on sequence variation imposed by functional conservation of molecules important for invasion (18) and that within the population, merozoites with surface molecules encoded by alternate alleles not recognized by existing antibodies or T lymphocytes may readily emerge.
| |
ACKNOWLEDGMENTS |
|---|
We thank Deb Alperin, Bev Hunter, and Carla Robertson for technical assistance, D. P. Jasmer for supplying the Sau3A genomic library, and Ignacio Echaide for providing the B. bovis strains from Argentina.
This work was supported by grants ARS CRIS-5348-32000-014-00D, USAID PCE-G-00-98-00043-00, and USDA NRI 96-35204-3667.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Animal Disease Research Unit, United States Department of Agriculture, Agricultural Research Service, Animal Disease Biotechnology Facility, Pullman, WA 99164-7030. Phone: (509) 335-6341. Fax: (509) 335-8328. E-mail: ces{at}vetmed.wsu.edu.
Permanent address: INEUCI, CONICET, Buenos Aires, Argentina.
Editor: W. A. Petri Jr.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Anziani, O. S., A. A. Guglielmone, A. A. Abdala, D. H Aguirre, and A. J. Mangold. 1993. Proteccion conferida por Babesia bovis vacunal en novillos Holando Argentino. Rev. Med. Vet. (Buenos Aires) 74:47-49. |
| 2. | Brown, W. C., G. H. Palmer, T. F. McElwain, S. A. Hines, and D. A. E. Dobbelaere. 1993. Babesia bovis: characterization of the T helper cell response against the 42-kDa merozoite surface antigen (MSA-1) in cattle. Exp. Parasitol. 77:97-110[CrossRef][Medline]. |
| 3. | Cowman, A. F., O. Bernard, N. Stewart, and D. J. Kemp. 1984. Genes of the protozoan parasite Babesia bovis that rearrange to produce RNA species with different sequences. Cell 37:653-660[CrossRef][Medline]. |
| 4. | Devereaux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387-395. |
| 5. | Graham, G. J. 1995. Tandem genes and clustered genes. J. Theor. Biol. 175:71-87[CrossRef][Medline]. |
| 6. | Hadley, T. J., R. W. Klotz, and L. H. Miller. 1986. Invasion of erythrocytes by malaria parasites: a cellular and molecular overview. Annu. Rev. Microbiol. 40:451-477[CrossRef][Medline]. |
| 7. | Hines, S. A., T. F. McElwain, G. B. Buening, and G. H. Palmer. 1989. Molecular characterization of Babesia bovis merozoite surface proteins bearing epitopes immunodominant in protected cattle. Mol. Biochem. Parasitol. 37:1-10[CrossRef][Medline]. |
| 8. | Hines, S. A., G. H. Palmer, D. P. Jasmer, W. L. Goff, and T. F. McElwain. 1995. Immunization of cattle with recombinant Babesia bovis merozoite antigen 1. Infect. Immun. 63:349-352[Abstract]. |
| 9. | Hines, S. A., G. H. Palmer, D. P. Jasmer, T. C. McGuire, and T. F. McElwain. 1992. Neutralization-sensitive merozoite surface antigens of Babesia bovis encoded by members of a polymorphic gene family. Mol. Biochem. Parasitol. 55:85-94[CrossRef][Medline]. |
| 10. |
Hofmann, K., and W. Stoffel.
1993.
TMbase a database of membrane spanning proteins segments.
Biol. Chem. Hoppe-Seyler
347:166.
|
| 11. | Howard, R. J., and B. L. Pasloske. 1993. Target antigens for asexual malaria vaccine development. Parasitol. Today 9:369-372[CrossRef][Medline]. |
| 12. | Jasmer, D. P., D. W. Reduker, S. A. Hines, L. E. Perryman, and T. C. McGuire. 1992. Surface epitope localization and gene structure of a Babesia bovis 44-kilodalton variable merozoite antigen. Mol. Biochem. Parasitol. 55:75-84[CrossRef][Medline]. |
| 13. |
Levi, M. G., and M. Ristic.
1980.
Babesia bovis: continuous cultivation in a microaerophilus stationary phase culture.
Science
207:1218-1220 |
| 14. | Madruga, C. R., C. E. Suarez, T. F. McElwain, and G. H. Palmer. 1996. Conservation of merozoite and apical complex B cell epitopes among Babesia bigemina and Babesia bovis strains isolated in Brazil. Vet. Parasitol. 61:21-30[CrossRef][Medline]. |
| 15. | Marshall, V. M., A. Silva, M. Foley, S. Cranmer, L. Wang, D. J. McColl, D. J. Kemp, and R. L. Coppel. 1997. A second merozoite surface protein (MSP-4) of Plasmodium falciparum that contains an epidermal growth factor-like domain. Infect. Immun. 65:4460-4467[Abstract]. |
| 16. | Marshall, V. M., W. Tieqiao, and R. L. Coppel. 1998. Close linkage of three merozoite surface protein genes on chromosome 2 of Plasmodium falciparum. Mol. Biochem. Parasitol. 94:13-25[CrossRef][Medline]. |
| 17. | Molloy, J. B., S. J. Waldron, and W. K. Jorgensen. 1995. Identification of an immunodominant 40 kDa merozoite antigen common to the Australian T and Dixie vaccine strains of Babesia bovis and the development of diagnostic tests specific for these strains. Vet. Parasitol. 60:229-240[CrossRef][Medline]. |
| 18. | O'Donnell, R. A., A. Saul, A. F. Cowman, and B. S. Crabb. 2000. Functional conservation of the malaria vaccine antigen MSP-119 across distantly related Plasmodium species. Nat. Med. 6:91-95[CrossRef][Medline]. |
| 19. | Palmer, D. A., G. M. Buening, and C. A. Carson. 1982. Cryopreservation of Babesia bovis for in vitro cultivation. Parasitology 84:567-571[Medline]. |
| 20. | Palmer, G. H., and T. F. McElwain. 1995. Molecular basis for vaccine development against anaplasmosis and babesiosis. Vet. Parasitol. 57:233-253[CrossRef][Medline]. |
| 21. |
Palmer, G. H.,
T. F. McElwain,
L. E. Perryman,
W. C. Davis,
D. R. Reduker,
D. J. Jasmer,
V. Shkap,
E. Pipano,
W. L. Goff, and T. C. McGuire.
1991.
Strain variation of Babesia bovis merozoite surface exposed epitopes.
Infect. Immun.
59:3340-3342 |
| 22. | Reduker, D. R., D. P. Jasmer, W. L. Goff, L. E. Perryman, W. C. Davis, and T. C. McGuire. 1989. A recombinant surface protein of Babesia bovis elicits antibodies that react with live merozoites. Mol. Biochem. Parasitol. 35:239-248[CrossRef][Medline]. |
| 23. | Ridley, R. G., B. Takacs, H. Etlinger, and J. G. Scaife. 1990. A rhoptry antigen of Plasmodium falciparum is protective in Saimiri monkeys. Parasitology 101:187-192. |
| 24. |
Sam Yellowe, T. Y.
1996.
Rhoptry organelles of the apicomplexa: their role in host cell invasion and intracellular survival.
Parasitol. Today
12:28-32.
|
| 25. | Saul, A., G. Lawrence, A. Smillie, C. M. Rzepczyk, C. Reed, D. Taylor, K. Anderson, A. Stowers, R. Kemp, A. Allworth, R. F. Anders, G. V. Brown, D. Pye, P. Schoofs, D. O. Irving, S. L. Dyer, G. C. Woodrow, W. R. Briggs, R. Reber, and D. Sturchler. 1999. Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant. Vaccine 17:3145-3159[CrossRef][Medline]. |
| 26. | Shkap, V., E. Pipano, T. F. McElwain, U. Herzberg, Y. Krigel, L. Fish, and G.H. Palmer. 1994. Cross-protective immunity induced by Babesia bovis clones with antigenically unrelated variable merozoite surface antigens. Vet. Immunol. Immunopathol. 41:367-374[CrossRef][Medline]. |
| 27. |
Siddiqui, W. A.,
L. Q. Tam,
K. J. Kramer,
G. S. Hui,
S. E. Case,
K. M. Yamaga,
S. P. Chang,
E. B. Chan, and S. C. Kan.
1987.
Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria.
Proc. Natl. Acad. Sci. USA
84:3014-3018 |
| 28. |
Suarez, C. E.,
T. F. McElwain,
I. E. Echaide,
S. T. de Echaide, and G. H. Palmer.
1994.
Interstrain conservation of babesial RAP-1 surface exposed epitopes despite rap-1 genomic polymorphism.
Infect. Immun.
62:3576-3579 |
| 29. | Suarez, C. E., G. H. Palmer, I. Hotzel, and T. F. McElwain. 1998. Structure, sequence, and transcriptional analysis of the Babesia bovis rap-1 multigene locus. Mol. Biochem. Parasitol. 93:215-224[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»